Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer
N Qu, RJ Lee, Y Sun, G Cai, J Wang… - International Journal …, 2016 - Taylor & Francis
Cabazitaxel-loaded human serum albumin nanoparticles (Cbz-NPs) were synthesized to
overcome vehicle-related toxicity of current clinical formulation of the drug based on Tween …
overcome vehicle-related toxicity of current clinical formulation of the drug based on Tween …
Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma
C Shi, H Yu, D Sun, L Ma, Z Tang, Q Xiao, X Chen - Acta biomaterialia, 2015 - Elsevier
Cisplatin-loaded poly (l-glutamic acid)-g-methoxy poly (ethylene glycol 5K) nanoparticles
(CDDP-NPs) were characterized and exploited for the treatment of non-small cell lung …
(CDDP-NPs) were characterized and exploited for the treatment of non-small cell lung …
Radiation sterilisation of doxorubicin bound to poly (butyl cyanoacrylate) nanoparticles
O Maksimenko, E Pavlov, E Toushov, A Molin… - International journal of …, 2008 - Elsevier
Doxorubicin-loaded poly (butyl cyanoacrylate)(PBCA) nanoparticles were prepared by
anionic polymerisation under non-aseptic conditions. The feasibility of sterilisation of this …
anionic polymerisation under non-aseptic conditions. The feasibility of sterilisation of this …
[HTML][HTML] Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer
The present study was carried out to develop cisplatin-loaded chitosan nanoparticles
(CCNP) and cisplatin-loaded chitosan nanoparticle surface linked to rituximab (mAbCCNP) …
(CCNP) and cisplatin-loaded chitosan nanoparticle surface linked to rituximab (mAbCCNP) …
[PDF][PDF] Pharmacokinetics and biodistribution studies of doxorubicin loaded poly (butyl cyanoacrylate) nanoparticles synthesized by two different techniques
LH Reddy, RS Murthy - Biomed Pap Med Fac Univ …, 2004 - pdfs.semanticscholar.org
The aim of the study is to determine and compare the pharmacokinetics and tissue
distribution of Doxorubicin (Dox) delivered as solution or through nanoparticles after …
distribution of Doxorubicin (Dox) delivered as solution or through nanoparticles after …
Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles
CE Soma, C Dubernet, D Bentolila, S Benita… - Biomaterials, 2000 - Elsevier
Individual and combined polyalkylcyanoacrylate nanoparticle formulation of cyclosporin A
and doxorubicin were prepared and evaluated in an attempt to show improved growth …
and doxorubicin were prepared and evaluated in an attempt to show improved growth …
Reduced toxicological manifestations of cisplatin following encapsulation in folate grafted albumin nanoparticles
N Alam, RD Dubey, A Kumar, M Koul, N Sharma… - Life sciences, 2015 - Elsevier
Aims Cisplatin is one of the most potent chemotherapeutic agents acting against a variety of
tumors, however, its use is mainly limited due to the dose limiting toxicities and acquired …
tumors, however, its use is mainly limited due to the dose limiting toxicities and acquired …
Encapsulation of cisplatin in a pegylated calcium phosphate nanoparticle (CPNP) for enhanced cytotoxicity to cancerous cells
Hypothesis Exchange of the chloride ion (Cl−) ligands of cisplatin with carboxylates is widely
used in fabricating cisplatin loaded nanoparticles for improved cancer therapy. However, the …
used in fabricating cisplatin loaded nanoparticles for improved cancer therapy. However, the …
Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles
Y Zhang, J Yu, L Zhang, J Cai, D Cai, C Lv - Tumor Biology, 2016 - Springer
For effective therapy for glioma, it is essential for chemotherapeutics to pass the blood-brain
barrier to target glioma cells with little side effects to surrounding normal cells. In this study …
barrier to target glioma cells with little side effects to surrounding normal cells. In this study …
Nanoparticle-based biocompatible and targeted drug delivery: characterization and in vitro studies
X Yu, MV Pishko - Biomacromolecules, 2011 - ACS Publications
Paclitaxel nanoparticles (PAX NPs) prepared with the size of 110±10 nm and ζ potential of−
40±3 mV were encapsulated in synthetic/biomacromolecule shell chitosan, dextran-sulfate …
40±3 mV were encapsulated in synthetic/biomacromolecule shell chitosan, dextran-sulfate …